Similarly, gene sets of checkpoint molecules and TIL (tumor-infiltrating lymphocytes) are also enriched in high-risk groups, which indicate effector T-cell deactivation under a higher expression of immune checkpoints like PD-1, TIM-3, and CTLA-4. This evidence concerns the gene CTLA4 and neoplasm.